NRXP
Price
$3.19
Change
-$0.12 (-3.63%)
Updated
Oct 21, 04:59 PM (EDT)
Capitalization
78.68M
Intraday Buy/Sell Signals
TVRD
Price
$5.73
Change
-$0.44 (-7.13%)
Updated
Oct 21, 04:59 PM (EDT)
Capitalization
57.86M
Intraday Buy/Sell Signals
Interact to see
Advertisement

NRXP vs TVRD

Header iconNRXP vs TVRD Comparison
Open Charts NRXP vs TVRDBanner chart's image
NRX Pharmaceuticals
Price$3.19
Change-$0.12 (-3.63%)
Volume$872
Capitalization78.68M
Tvardi Therapeutics
Price$5.73
Change-$0.44 (-7.13%)
Volume$8.14K
Capitalization57.86M
NRXP vs TVRD Comparison Chart in %
NRXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TVRD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NRXP vs. TVRD commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRXP is a Buy and TVRD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 21, 2025
Stock price -- (NRXP: $3.31 vs. TVRD: $6.17)
Brand notoriety: NRXP and TVRD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRXP: 85% vs. TVRD: 156%
Market capitalization -- NRXP: $78.68M vs. TVRD: $57.86M
NRXP [@Biotechnology] is valued at $78.68M. TVRD’s [@Biotechnology] market capitalization is $57.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRXP’s FA Score shows that 0 FA rating(s) are green whileTVRD’s FA Score has 1 green FA rating(s).

  • NRXP’s FA Score: 0 green, 5 red.
  • TVRD’s FA Score: 1 green, 4 red.
According to our system of comparison, both NRXP and TVRD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRXP’s TA Score shows that 5 TA indicator(s) are bullish while TVRD’s TA Score has 5 bullish TA indicator(s).

  • NRXP’s TA Score: 5 bullish, 5 bearish.
  • TVRD’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both NRXP and TVRD are a good buy in the short-term.

Price Growth

NRXP (@Biotechnology) experienced а +6.09% price change this week, while TVRD (@Biotechnology) price change was -7.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.72%. For the same industry, the average monthly price growth was +22.80%, and the average quarterly price growth was +72.04%.

Industries' Descriptions

@Biotechnology (+8.72% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRXP($78.7M) has a higher market cap than TVRD($57.9M). NRXP YTD gains are higher at: 50.455 vs. TVRD (0.817). TVRD has more cash in the bank: 21.4M vs. NRXP (2.91M). TVRD has less debt than NRXP: TVRD (254K) vs NRXP (10.2M).
NRXPTVRDNRXP / TVRD
Capitalization78.7M57.9M136%
EBITDA-33.79MN/A-
Gain YTD50.4550.8176,176%
P/E Ratio0.36N/A-
Revenue0N/A-
Total Cash2.91M21.4M14%
Total Debt10.2M254K4,016%
FUNDAMENTALS RATINGS
NRXP vs TVRD: Fundamental Ratings
NRXP
TVRD
OUTLOOK RATING
1..100
7352
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
18
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3934
P/E GROWTH RATING
1..100
93100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TVRD's Valuation (18) in the null industry is in the same range as NRXP (44). This means that TVRD’s stock grew similarly to NRXP’s over the last 12 months.

TVRD's Profit vs Risk Rating (100) in the null industry is in the same range as NRXP (100). This means that TVRD’s stock grew similarly to NRXP’s over the last 12 months.

TVRD's SMR Rating (100) in the null industry is in the same range as NRXP (100). This means that TVRD’s stock grew similarly to NRXP’s over the last 12 months.

TVRD's Price Growth Rating (34) in the null industry is in the same range as NRXP (39). This means that TVRD’s stock grew similarly to NRXP’s over the last 12 months.

NRXP's P/E Growth Rating (93) in the null industry is in the same range as TVRD (100). This means that NRXP’s stock grew similarly to TVRD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NRXPTVRD
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 22 days ago
81%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 9 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
65%
View a ticker or compare two or three
Interact to see
Advertisement
NRXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TVRD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STBXF0.170.04
+30.66%
Starbox Group Holdings Ltd.
BDNNY88.741.85
+2.13%
Boliden AB
ECRAF1.210.02
+1.68%
ECORA RESOURCES PLC
HSTI1.40N/A
N/A
High Sierra Technologies Inc.
APMSF30.50N/A
N/A
Aperam S.A.

NRXP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRXP has been closely correlated with RNAC. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRXP jumps, then RNAC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXP
1D Price
Change %
NRXP100%
+4.09%
RNAC - NRXP
86%
Closely correlated
+8.21%
NCNA - NRXP
85%
Closely correlated
-1.97%
TAOX - NRXP
84%
Closely correlated
+24.76%
ALLR - NRXP
81%
Closely correlated
+4.86%
PALI - NRXP
74%
Closely correlated
+6.90%
More

TVRD and

Correlation & Price change

A.I.dvisor tells us that TVRD and COEP have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TVRD and COEP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TVRD
1D Price
Change %
TVRD100%
-6.23%
COEP - TVRD
32%
Poorly correlated
-1.63%
VSTM - TVRD
25%
Poorly correlated
-13.02%
NRXP - TVRD
25%
Poorly correlated
+4.09%
APM - TVRD
24%
Poorly correlated
+3.23%
ONCO - TVRD
24%
Poorly correlated
+1.48%
More